1 study found for:    23306000 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily
Condition: Infection, Human Immunodeficiency Virus I
Interventions: Drug: GSK1349572;   Drug: raltegravir;   Other: Placebo;   Other: ABC/3TC;   Other: TDF/FTC

Indicates status has not been verified in more than two years